Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes

Journal of the National Cancer Institute

Volumn 90, Issue 15, 1998, Pages 1130-1137

  Zou, Yiyu ^a   Zong, Gang ^a   Ling, Yi He ^a   Hao, Ming Ming ^b   Lozano, Guillermina ^b   Hong, Waun K ^a   Perez Soler, Roman ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRONCHUS CANCER; CANCER THERAPY; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032486794     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.15.1130     Document Type: Article

References (34)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997 [published erratum appears in CA Cancer J Clin 1997;47:68]. CA Cancer J Clin 1997;47:5-27.
2. Minna DJ. Tumor suppressor genes and oncogenes in lung cancer: potential clinical applications. Adv Oncol 1996;12:3-8.
3. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
4. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89:1366-73.
5. Rusch V, Klimstra D, Linkov I, Dmitrovsky E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res 1995;55:1365-72.
6. Bennett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993;53:4817-22.
7. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
8. Lower SW. Cancer therapy and p53. Curr Opin Oncol 1995;7:547-53.
9. Reeve JG, Xiong J, Morgan J, Bleehen NM. Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br J Cancer 1996;73:1193-200.
10. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 1996;2:985-91.
11. Van Ginkel FW, Liu C, Simecka JW, Dong JY, Greenway T, Frizzell RA, et al. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase. Hum Gene Ther 1995;6:895-903.
12. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987;84:7413-7.
13. Canonico AE, Plitman JD, Conary JT, Meyrick BO, Brigham KL. No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. J Appl Physiol 1994;77:415-9.
14. Scheule RK, St George JA, Bagley RG, Marshall J, Kaplan JM, Akita GY, et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 1997;8:689-707.
15. Lesoon-Wood LA, Kim WH, Kleinman HK, Weintraub BD, Mixson AJ. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther 1995;6: 395-405.
16. Brigham KL, Meyrick B, Christman B, Magnuson M, King G, Berry LC Jr. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am J Med Sci 1989;298:278-81.
17. Canonico AE, Conary JT, Meyrick BO, Brigham KL. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits. Am J Respir Cell Mol Biol 1994;10:24-9.
18. Yoshimura K, Rosenfeld MA, Nakamura H, Scherer EM, Pavirani A, Lecocq JP, et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992;20:3233-40.
19. Alton EW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice [published erratum appears in Nat Genet 1993;5:312]. Nat Genet 1993;5:135-42.
20. Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R. Aerosol gene delivery in vivo. Proc Natl Acad Sci U S A 1992;89:11277-81.
21. Hyde SC, Gill DR, Higgins CF, Trezise AE, MacVinish LJ, Cuthbert AW, et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993;362:250-5.
22. Hazinski TA, Ladd PA, DeMatteo CA. Localization and induced expression of fusion genes in the rat lung. Am J Respir Cell Mol Biol 1991;4: 206-9.
23. Logan JJ, Bebok Z, Walker LC, Peng S, Felgner PL, Siegal GP, et al. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium. Gene Ther 1995;2:38-49.
24. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996;7:1701-17.
25. Eastman SJ, Tousignant JD, Lukason MJ, Murray H, Siegel CS, Constantino P, et al. Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid : DNA complexes. Hum Gene Ther 1997;8:313-22.
26. Eastman SJ, Lukason MJ, Tousignant JD, Murray H, Lane MD, St George JA, et al. A concentrated and stable aerosol formulation of cationic lipid : DNA complexes giving high-level gene expression in mouse lung. Hum Gene Ther 1997;8:765-73.
27. Karasuyama H, Tohyama N, Tada T. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J Exp Med 1989;169:13-25.
28. Lamb P, Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986;6:1379-85.
29. Tuck SP, Crawford L. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion. Oncogene Res 1989;4: 81-96.
30. McCoy RD, Davidson BL, Roessler BJ, Huffnagle GB, Janich SL, Laing TJ, et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum Gene Ther 1995;6:553-60.
31. Goldman MJ, Litzky LA, Engelhardt JF, Wilson JM. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Hum Gene Ther 1995;6:839-51.
32. Katkin JP, Gilbert BE, Langston C, French K, Beaudet AL. Aerosol delivery of a β-galactosidase adenoviral vector to the lungs of rodents. Hum Gene Ther 1995;6:985-95.
33. Sene C, Bout A, Imler JL, Schultz H, Willemot JM, Hennebel V, et al. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum Gene Ther 1995;6:1587-93.
34. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res 1997;57:5489-92.